Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Financing done at 11.6 cents pre-consolidation numbers
View:
Post by XRRH2008 on Sep 20, 2017 10:48am

Financing done at 11.6 cents pre-consolidation numbers

Pathetic. Embarrasing. This stock just continues to sink to new lows with Allison at the helm.
Seems like the plan all along was to drive down the share price so new blood (including Allison probably) could buy in at much lower price and get more of the company.
Comment by DIYGuy on Sep 25, 2017 10:27am
I understand your frustration. I don't buy into conspiracy theories. The bottom line is there was delays in the trial and the stock price got hammered. The financing gives us another chance. Let's hope the HNSCC goes smoothly. The sellers appear to be taking a little break. Hope the floor has been set. Also, hope the money is used for the trials and not wasted on the PR firms.
Comment by DIYGuy on Sep 27, 2017 7:50am
Share price won't move until 2nd round of financing closes in a couple of weeks. You could sell your shares at current prices to purchase the units. Basically half the risk as you can exercise the warrant for $1.21 for a year unless the price doubles sooner. So, if they release the news of the dosing in the HNSCC trial it will have no effect on the share price. If the volume increases people ...more  
Comment by Cotitwo on Sep 28, 2017 7:48am
I believe they all did. I think it was published on Sedar September 23-24.John Drake $100k Alison $50K  Directors Gene Kelly $10K.and there is the second traunch as well 
Comment by DIYGuy on Sep 28, 2017 5:36pm
I do not see the documents on Sedar. I'll take your word for it. Can't say if those amounts are significant or not without knowing people's personal situations. I would be concerned if they did not participate. I realize they don't have to with the options they receive, but why would anyone put their faith in their discoveries if they don't risk some of their own money as well. ...more  
Comment by UberWealth on Nov 27, 2017 7:59am
More Financing needed?  Previous financing done at such a dilutive price!  Tax loss selling season?  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities